Effect of vanadium on human dendritic cells

Toxicological and Environmental Chemistry

Volumn 92, Issue 2, 2010, Pages 355-371

  Chan, Erwin P H ^a   Filgueira, Luis ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Dendritic cell; Human; Immune reactivity; In vitro; Vanadium

Indexed keywords

CELL MEMBRANES; CYTOLOGY; HEAVY METALS; IMMUNE SYSTEM; LYMPHOCYTES; MEDICAL APPLICATIONS; MOLECULES; VANADIUM;

ADAPTIVE IMMUNE RESPONSE; CELL SURFACE MOLECULES; DENDRITIC CELLS; ENVIRONMENTAL EXPOSURE; FLOW CYTOMETRY ANALYSIS; HUMAN; IN-VITRO; VANADIUM CONCENTRATION;

VANADIUM COMPOUNDS;

BLOOD; CYTOLOGY; FLOW CYTOMETRY; HOMINID; IMMUNE SYSTEM; MATURATION; MITOCHONDRION; TOXICITY; VANADIUM;

EID: 75849150456     PISSN: 02772248     EISSN: 10290486     Source Type: Journal    
DOI: 10.1080/02772240902863848     Document Type: Article

References (61)

1. Altamirano-Lozano, M. 1998. Genotoxic effects of vanadium compounds. Journal of Clinical Investigation 39, no. Suppl 1: 39-47.
2. Anke, M. 2004. Vanadium - An element both essential and toxic to plants, animals and humans? Anales Real Academia Nacional De Farmacia 70: 961-99.
3. Bainbridge, J.A., P.A. Revell, and N. Al-Saffar. 2001. Costimulatory molecule expression following exposure to orthopaedic implants wear debris. Journal of Biomedical Materials Research 54: 328-34.
4. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annual Review of Immunology 18: 767-811.
5. Barceloux, D.G. 1999. Vanadium. Journal of Toxicology - Clinical Toxicology 37: 265-78.
6. Bernheim, F., and M.L. Bernheim. 1938. Action of vanadium on tissue oxidations. Science 88: 481-2.
7. Brien, W.W., E.A. Salvati, F. Betts, P. Bullough, T. Wright, C. Rimnac, R. Buly, and K. Garvin. 1992. Metal levels in cemented total hip arthroplasty. A comparison of well-fixed and loose implants. Clinical Orthopaedics and Related Research 276: 66-274.
8. Calhoun, R.F., W.F. Oppat, B. Duffy, and T. Mohanakumar. 1999. Intercellular adhesion molecule-1/leukocyte function associated antigen-1 blockade inhibits alloantigen specific human T cell effector functions without inducing energy. Transplantation 68: 1144-52.
9. Carramolino, L., L. Kremer, I. Goya, R. Varona, J.M. Buesa, J. Gutierrez, A. Zaballos, C. Martínez-A, and G. Márquez. 1999. Down-regulation of the beta-chemokine receptor CCR6in dendritic cells mediated by TNF-alpha and IL-4. Journal of Leukocyte Biology 66: 837-44.
10. Chan, E.P., A. Mhawi, P. Clode, M. Saunders, and L. Filgueira. 2009. Effects of titanium(iv) ions on human monocyte-derived dendritic cells. Metallomics 1: 166-74.
11. Cohen, M.D., M. Sisco, C. Prophete, L. Chen, J.T. Zelikoff, A.J. Ghio, J.D. Stonehuerner, J.J. Smee, A.A. Holder, and D.C. Crans. 2007. Pulmonary immunotoxic potentials of metals are governed by select physicochemical properties: Vanadium agents. International Journal of Immunotoxicology 4: 49-60.
12. Crans, D.C., J.J. Smee, E. Gaidamauskas, and L. Yang. 2004. The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. Chemical Reviews 104: 849-902.
13. Desoize, B. 2004. Metals and metal compounds in cancer treatment. Anticancer Research 24: 1529-44.
14. Di Gioacchino, M., E. Sabbioni, L. Di Giampaolo, C. Schiavone, M.B. Di Sciascio, M. Reale, V. Nicola, et al. 2002. In vitro effects of vanadate on human immune functions. Annals of Clinical and Laboratory Science 32: 148-54.
15. Dorner, T., J. Haas, C. Loddenkemper, V. Von Baehr, and A. Salama. 2006. Implant-related inflammatory arthritis. Nature Clinical Practice Rheumatology 2: 53-6.
16. Elberg, G., J. Li, and Y. Shechter. 1994. Vanadium activates or inhibits receptor and nonreceptor protein tyrosine kinases in cell-free experiments, depending on its oxidation state. Possible role of endogenous vanadium in controlling cellular protein tyrosine kinase activity. Journal of Biological Chemistry 269: 9521-7.
17. Fortoul, T.I., A. Quan-Torres, I. Sanchez, I.E. Lopez, P. Bizarro, M.L. Mendoza, L.S. Osorio, et al. 2002. Vanadium in ambient air: concentrations in lung tissue from autopsies of Mexico City residents in the 1960s and 1990s. Archives of Environmental Health 57: 446-9.
18. Granchi, D., E. Cenni, D. Tigani, G. Trisolino, N. Baldini, and A. Giunti. 2008. Sensitivity to implant materials in patients with total knee arthroplasties. Biomaterials 29: 1494-500.
19. Granchi, D., E. Cenni, G. Trisolino, A. Giunti, and N. Baldini. 2005. Sensitivity to implant materials in patients undergoing total hip replacement. Journal of Biomedical Materials Research Part B Applied Biomaterials 77: 257-64.
20. Gristina, A.G. 1994. Implant failure and the immuno-incompetent fibro-inflammatory zone. Clinical Orthopaedics and Related Research 298: 106-18.
21. Guironnet, G., C. Dalbiez-Gauthier, F. Rousset, D. Schmitt, and J. Peguet-Navarro. 2000. In vitro human T cell sensitization to haptens by monocyte-derived dendritic cells. Toxicology In Vitro 14: 517-22.
22. Hallab, N.J., S. Anderson, M. Caicedo, A. Brasher, K. Mikecz, and J.J. Jacobs. 2005. Effects of soluble metals on human peri-implant cells. Journal of Biomedical Materials Research Part A 74: 124-40.
23. Hallab, N.J., M. Caicedo, A. Finnegan, and J.J. Jacobs. 2008. Th1 type lymphocyte reactivity to metals in patients with total hip arthroplasty. Journal of Orthopaedic Surgery and Research 3: 6.
24. Hanawa, T. 2004. Metal ion release from metal implants. Materials Science and Engineering C- Biomimetics andSupramolecularSystems 24: 745-52.
25. Hogan, G.R. 2000. Comparative erythropoietic effects of three vanadium compounds. Science of the Total Environment 256: 185-9.
26. Hulette, B.C., C.A. Ryan, L.A. Gildea, and G.F. Gerberick. 2005. Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen. Toxicology and Applied Pharmacology 209: 159-66.
27. Hulette, B.A., C.A. Ryan, B.C. Hulette, and G.F. Gerberick. 2002. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicology and Applied Pharmacology 182: 226-33.
28. Huyer, G., S. Liu, J. Kelly, J. Moffat, P. Payette, B. Kennedy, G. Tsaprailis, M.J. Gresser, and C. Ramachandran. 1997. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. Journal of Biological Chemistry 272: 843-51.
29. Hymery, N., Y. Sibiril, and D. Parent-Massin. 2006. Improvement of human dendritic cell culture for immunotoxicological investigations. Cell Biology and Toxicology 22: 243-55.
30. Irsigler, G.B., P.J. Visser, and P.A. Spangenberg. 1999. Asthma and chemical bronchitis in vanadium plant workers. American Journal of Industrial Medicine 35: 366-74.
31. Ivancsits, S., A. Pilger, E. Diem, A. Schaffer, and H.W. Rudiger. 2002. Vanadate induces DNA strand breaks in cultured human fibroblasts at doses relevant to occupational exposure. Mutation Research 519: 25-35.
32. Jacobs, J.J., J.L. Gilbert, and R.M. Urban. 1998. Corrosion of metal orthopaedic implants. Journal of Bone and Joint Surgery 80: 268-82.
33. Jeras, M., M. Bergant, and U. Repnik. 2005. In vitro preparation and functional assessment of human monocyte-derived dendritic cells-potential antigen-specific modulators of in vivo immune responses. Transplant Immunology 14: 231-44.
34. Kasai, Y., R. Iida, and A. Uchida. 2003. Metal concentrations in the serum and hair of patients with titanium alloy spinal implants. Spine 28: 1320-6.
35. Katou, F., H. Ohtani, T. Nakayama, K. Ono, K. Matsushima, A. Saaristo, H. Nagura, O. Yoshie, and K. Motegi. 2001. Macrophage-derived chemokine (MDC/CCL22) and CCR4 are involved in the formation of T-lymphocyte-dendritic cell clusters in human inflamed skin and secondary lymphoid tissue. American Journal of Pathology 158: 1263-70.
36. Kitani, S. 2000. Allergy due to occupational vanadium exposure. Ryōikibetsu shōkōgun shirīzu 31: 636-8.
37. Lagorio, S., F. Forastiere, R. Pistelli, I. Iavarone, P. Michelozzi, V. Fano, A. Marconi, G. Ziemacki, and B.D. Ostro. 2006. Air pollution and lung function among susceptible adult subjects: A panel study. Environmental Health 5:11.
38. Manome, H., S. Aiba, and H. Tagami. 1999. Simple chemicals can induce maturation and apoptosis of dendritic cells. Immunology 98: 481-90.
39. Merritt, K., and S.A. Brown. 1995. Distribution of titanium and vanadium following repeated injection of high-dose salts. Journal of Biomedical Materials Research 29: 1175-8.
40. Mukherjee, B., B. Patra, S. Mahapatra, P. Banerjee, A. Tiwari, and M. Chatterjee. 2004. Vanadium - An element of atypical biological significance. Toxicology Letters 150: 135-43.
41. Musk, A.W., and J.G. Tees. 1982. Asthma caused by occupational exposure to vanadium compounds. The Medical Journal of Australia 1: 183-4.
42. Nagaoka, M.H., T. Yamazaki, and T. Maitani. 2002. Binding patterns of vanadium ions with different valence states to human serum transferrin studied by HPLC/high-resolution ICP-MS. Biochemical and Biophysical Research Communications 296: 1207-14.
43. Nechay, B.R., L.B. Nanninga, and P.S. Nechay. 1986. Vanadyl (IV) and vanadate (V) binding to selected endogenous phosphate, carboxyl, and amino ligands; calculations of cellular vanadium species distribution. Archives of Biochemistry and Biophysics 251: 128-38.
44. Nemery, B. 1990. Metal toxicity and the respiratory tract. European Respiratory Journal 3: 202-19.
45. Ouellet, M., J. Roy, B. Barbeau, R. Geleziunas, and M.J. Tremblay. 2003. NF-kappaB induction by bisperoxovanadium compounds requires CD45, p36(LAT), PKC, and IKK activity and exhibits kinetics of activation comparable to those of TCR/CD28 coengagement. Biochemistry 42: 8260-71.
46. Pinon-Zarate, G., V. Rodriguez-Lara, M. Rojas-Lemus, M. Martinez-Pedraza, A. Gonzalez-Villalva, P. Mussali-Galante, et al. 2008. Vanadium pentoxide inhalation provokes germinal center hyperplasia and suppressed humoral immune responses. Journal of Immunotoxicology 5: 115-22.
47. Qureshi, M.A., C.H. Hill, and C.L. Heggen. 1999. Vanadium stimulates immunological responses of chicks. Veterinary Immunology and Immunopathology 68: 61-71.
48. Rehder, D. 1992. Structure and function of vanadium compounds in living organisms. Biometals 5: 3-12.
49. Rodriguez-Mercado, J.J., E. Roldan-Reyes, and M. Altamirano-Lozano. 2003. Genotoxic effects of vanadium(IV) in human peripheral blood cells. Toxicology Letters 144: 359-69.
50. Sargeant, A., and T. Goswami. 2007. Hip implants - Paper VI - Ion concentrations. Mater Design 28: 155-71.
51. Schuster, G.S., and G.B. Caughman. 2004. Alterations of cell lipids by metal salts. Journal of Biomedical Materials Research Part A 70: 347-53.
52. Sekar, N., J. Li, and Y. Shechter. 1996. Vanadium salts as insulin substitutes: Mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research. Critical Reviews in Biochemistry and Molecular Biology 31: 339-59.
53. Shettlemore, M.G., and K.J. Bundy. 1999. Toxicity measurement of orthopedic implant alloy degradation products using a bioluminescent bacterial assay. Journal of Biomedical Materials Research 45: 395-403.
54. Sjoberg, S.G.1951. Possible importance of allergy in diseases caused by inhalation of inorganic dust. Acta Allergologica 4: 357-61.
55. Smith, D.M., R.M. Pickering, and G.T. Lewith. 2008. A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus. Quarterly Journal of Medicine 101: 351-8.
56. Staffolani, N., F. Damiani, C. Lilli, M. Guerra, N.J. Staffolani, S. Belcastro, and P. Locci. 1999. Ion release from orthodontic appliances. Journal of Dentistry 27: 449-54.
57. Thompson, K.H., and C. Orvig. 2006. Vanadium in diabetes: 100 years from Phase 0 to Phase I. Journal of Inorganic Biochemistry 100: 1925-35.
58. Tuschl, H., R. Kovac, and E. Weber. 2000. The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. Toxicology In Vitro 14: 541-9.
59. Valko, M., H. Morris, and M.T. Cronin. 2005. Metals, toxicity and oxidative stress. Current Medicinal Chemistry 12: 1161-208.
60. Vandenplas, O., F. Binard-Van Cangh, J. Gregoire, A. Brumagne, and A. Larbanois. 2002. Fever and neutrophilic alveolitis caused by a vanadium-based catalyst. Journal of Occupational and Environmental Medicine 59: 785-7.
61. Zychlinski, L., and J.Z. Byczkowski. 1990. Inhibitory effects of vanadium pentoxide on respiration of rat liver mitochondria. Archives of Environmental Contamination and Toxicology 19: 138-42.